| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 3,373 | $44.62 | $150,499.89 | -1.6% | -11.9% | - | |
| Nov 10, 2025 | EKSO Ekso Bionics Holdings, Inc. | Wong Jerome55 | Chief Financial Officer | Sell | 11,288 | $4.80 | $54,182.40 | -30.3% | +99.6% | - | |
| Nov 10, 2025 | IRTC Irhythm Holdings, Inc. | Talwalkar Abhijit Y56 | Director | Sell | 5,312 | $174.13 | $924,961.65 | -3.9% | -15.8% | - | |
| Nov 10, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 6,351 | $2.62 | $16,639.62 | -2.2% | +5.1% | - | |
| Nov 10, 2025 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 7,059 | $2.62 | $18,494.58 | -5.6% | +5.1% | - | |
| Nov 10, 2025 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Chief Operating Officer | Sell | 9,723 | $4.80 | $46,670.40 | -26.3% | +99.6% | - | |
| Nov 10, 2025 | INCY Incyte Corp | Hoppenot Herve | Director | Sell | 187,500 | $105.46 | $19,773,750.00 | -36.3% | +2.9% | - | |
| Nov 10, 2025 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 13,000 | $83.08 | $1,080,093.43 | -12.6% | -8.7% | - | |
| Nov 10, 2025 | AORT Artivion, Inc. | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 2,566 | $44.62 | $114,492.35 | -4.0% | -11.9% | - | |
| Nov 10, 2025 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 7,767 | $2.62 | $20,349.54 | -4.9% | +5.1% | - | |
| Nov 10, 2025 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 105 | $560.00 | $58,800.00 | -100% | -14.5% | - | |
| Nov 10, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul78 | Chief Data Officer | Sell | 7,073 | $2.62 | $18,531.26 | -4.0% | +5.1% | - | |
| Nov 10, 2025 | Rhoads Ann D47 | Director | Sell | 10,000 | $81.80 | $818,000.00 | -23.4% | +1.4% | - | ||
| Nov 7, 2025 | IDXX Idexx Laboratories Inc /de | Hunt Nimrata66 | Executive Vice President | Sell | 9,425 | $703.34 | $6,629,013.53 | -9.2% | -9.2% | - | |
| Nov 7, 2025 | SENS Senseonics Holdings, Inc. | Roeder Douglas A69 | Director | Buy | 15,000 | $5.83 | $87,450.00 | +17.7% | +15.0% | - | |
| Nov 7, 2025 | SINT Sintx Technologies, Inc. | Honigblum Gregg R. | Chief Investment Officer | Buy | 10,000 | $3.19 | $31,900.00 | +7.5% | -11.3% | - | |
| Nov 7, 2025 | BVS Bioventus Inc. | McMurry-Heath Michelle49 | Director | Sell | 17,701 | $7.42 | $131,254.69 | -23.7% | +10.2% | - | |
| Nov 7, 2025 | ESTA Establishment Labs Holdings Inc. | Jw Asset Management, LLC61 | 10% Owner | Sell | 2,500 | $65.09 | $162,725.00 | - | +2.1% | - | |
| Nov 7, 2025 | BDX Becton Dickinson & Co | Scott Bertram L48 | Director | Sell | 217 | $176.58 | $38,317.86 | -0.6% | +16.8% | - | |
| Nov 7, 2025 | SENS Senseonics Holdings, Inc. | Goodnow Timothy T76 | President And CEO | Buy | 17,210 | $5.87 | $101,022.70 | +2.7% | +15.0% | - | |
| Nov 7, 2025 | ZOMDF Zomedica Corp. | Klass Russell Kevin | Sr Vice President, Sales | Buy | 5,000 | $0.10 | $475.00 | - | - | - | |
| Nov 7, 2025 | ITGR Integer Holdings Corp | Smith Diron | EVP, Chief Financial Officer | Buy | 1,116 | $67.19 | $74,967.04 | +17.0% | +24.9% | - | |
| Nov 7, 2025 | RMD Resmed Inc | Farrell Michael J.63 | Chairman And CEO | Sell | 8,011 | $249.75 | $2,000,772.89 | -1.7% | +6.2% | - | |
| Nov 7, 2025 | SENS Senseonics Holdings, Inc. | Sullivan Frederick T. | Chief Financial Officer | Buy | 5,415 | $5.88 | $31,840.20 | +3.6% | +15.0% | - | |
| Nov 6, 2025 | ITGR Integer Holdings Corp | Capps Cheryl C50 | Director | Buy | 1,600 | $66.70 | $106,720.00 | +15.8% | +28.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.